Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi Winthrop Industrie Gentilly FR
01 1Sodium valproate
01 1France
01 1Valid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2004-198 - Rev 05
Status : Valid
Issue Date : 2024-02-06
Type : Chemical
Substance Number : 678
20
Sanofi Winthrop Industrie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Sodium valproate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2004-198 - Rev 05
This Chemical Type CEP, issued on February 06, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 678 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?
